文献速递生殖医学

生长激素联合治疗用于体外受精周期中低反应者的系统综述与Meta分析

Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2020-06-16

该系统综述与Meta分析纳入12项随机对照试验,比较低反应者接受生长激素联合治疗与常规控制性卵巢刺激的体外受精/卵胞浆内单精子注射结局。结果显示生长激素未提高活产率、流产率或持续妊娠率,但提高了临床妊娠率、获卵数、成熟卵母细胞数和可移植胚胎数。

要点

  • 生长激素联合治疗未提高低反应者的活产率。
  • 生长激素联合治疗提高了临床妊娠率、获卵数、成熟卵母细胞数和可移植胚胎数。
  • 敏感性和亚组分析未对合并结果产生统计学改变。

核心结论

  • 本Meta分析提供证据表明,生长激素补充可能改善低反应者的部分生殖结局,但未提高活产率。

研究设计与样本

  • 系统综述与Meta分析,纳入12项随机对照试验,比较低反应者接受生长激素联合治疗与常规控制性卵巢刺激的体外受精/卵胞浆内单精子注射周期。
  • 干预组586名女性,对照组553名女性。
  • 本综述在数据提取前于PROSPERO数据库注册(CRD42020151681)。

主要发现

  • 接受生长激素补充的患者未显示活产率、流产率或持续妊娠率增加。
  • 生长激素补充提高了临床妊娠率。
  • 生长激素补充增加了获卵数(均数差1.62)。
  • 生长激素补充增加了成熟(减数第二次分裂中期[MII])卵母细胞数(均数差2.06)。
  • 生长激素补充增加了可移植胚胎数(均数差0.76)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effectiveness of growth hormone (GH) supplementation in improving the in vitro fertilization (IVF) outcomes of poor responders. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Poor ovarian responders undergoing conventional IVF or intracytoplasmic sperm injection (ICSI). INTERVENTION(S): Randomized controlled trials (RCTs) of poor ovarian responders undergoing a single IVF/ICSI cycle with GH supplementation versus conventional controlled ovarian stimulation. This review was registered in the PROSPERO database before starting data extraction (CRD42020151681). MAIN OUTCOME MEASURE(S): Primary outcome was live birth rate. Clinical pregnancy rate, miscarriage rate, ongoing pregnancy rate, number of oocytes, number of mature (metaphase II [MII]) oocytes and the number of embryos available to transfer were considered as secondary outcomes. RESULT(S): Twelve RCTs were included; 586 women were assigned to the intervention group and 553 to the control group. The analysis revealed that patients receiving GH supplementation did not show an increased live birth rate, miscarriage rate, or ongoing pregnancy rate. However, GH supplementation in poor responders increased clinical pregnancy rate, number of oocytes retrieved (mean difference 1.62), number of MII oocytes (mean difference 2.06), and number of embryos available to transfer (mean difference 0.76). Sensitivity and subgroup analyses did not provide statistical changes to pooled results. CONCLUSION(S): The present meta-analysis provides evidence that GH supplementation may improve some reproductive outcomes in poor responders, but not live birth rates.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Cozzolino M, Cecchino GN, Troiano G, et al. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril. 2020. PMID: 32553470. doi:10.1016/j.fertnstert.2020.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。